SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
Teen drug use remains low, but survey finds small rise in heroin and cocaine use - 2Figure out How to Really focus on Your Dental Inserts for Durable Outcomes
- 3Gauging the Upsides and downsides of Visas: A Complete Aide
- 4‘Wicked: For Good’ streaming release — How to watch the sequel starring Ariana Grande and Cynthia Erivo
- 56 Tire Brands Reasonable for Seniors
- South Korea launches Earth-observation satellite on homegrown Nuri rocket
- Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
- Unsold Rams May Be Less expensive Than You Suspect
- What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
- 'Stranger Things' Season 5: When does Volume 2 come out? And Volume 3? Everything to know about the remaining episodes before the finale.
- Our 10 favorite Space.com reader astronomy photos of 2025
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
- 3 back-to-back storms forecast to bring snow and surges of cold air across the Midwest to the Northeast
- The Most recent Microsoft Surface Star PC: Ideal for Top of the line Planning and Gaming Needs
